SITE009-0070

SITE009 (AUS) › SITE009-0070

SITE009-0070

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2025-11-26

enrolled

AEs

6

Serious

0

Dropout signal

–

Adverse events

6

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-02-16 (study day 260); relationship: not assessed

mild assessed

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-14 (study day 258); relationship: not assessed

mild assessed

Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-01-30 (study day 243); relationship: NOT RELATED

moderate assessed

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-09-21 (study day 112); relationship: not assessed

mild assessed

Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-09-16 (study day 107); relationship: not assessed

mild assessed

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-08-29 (study day 89); relationship: NOT RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.